Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anemia, Aplastic (Phase 2)
Anemia, Diamond-Blackfan (Phase 1/Phase 2)
Anemia, Sickle Cell (Phase 1/Phase 2)
beta-Thalassemia (Phase 1/Phase 2)
Bone Marrow Failure Disorders (Phase 2)
Graft vs Host Disease (Phase 2/Phase 3)
Hematologic Neoplasms (Phase 1)
Hematopoietic Stem Cell Transplantation (Phase 1)
Hodgkin Disease (Phase 2)
Immune System Diseases (Phase 1/Phase 2)
Leukemia (Phase 2/Phase 3)
Leukemia, Biphenotypic, Acute (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Lymphoma (Phase 2/Phase 3)
Lymphoma, Non-Hodgkin (Phase 2)
Myelodysplastic Syndromes (Phase 2/Phase 3)
Opportunistic Infections (Phase 2/Phase 3)
Plasmacytoma (Phase 2)
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (Phase 1/Phase 2)
Primary Immunodeficiency Diseases (Phase 2)
Sarcoma, Myeloid (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue